Posted by Michael Wonder on 28 Apr 2022
COVID-19 vaccine weekly safety report (28 April 2022)
28 April 2022 - To 24 April 2022, the TGA has received 544 reports which have been assessed as likely to be myocarditis from about 39.4 million doses of Comirnaty (Pfizer) and 86 reports which have been assessed as likely to be myocarditis from about 4.2 million doses of Spikevax (Moderna).
No new cases of thrombosis with thrombocytopenia syndrome related to the AstraZeneca vaccine have been reported this year
